Application of DCF and rDCF methods valuation to pharmaceutical projects

Cover Page

Abstract


The paper examines problems of analysis of projects in the sphere of pharmaceuticals. It is underlined that in the case of pharmaceuticals traditional approach based on discounted cash flows can not meet the requirements because of the unexpected risks and profits. So additional tools are required. For this purpose the paper proposes strategic net present value (rNPV). The method allows take to account managerial flexibility and consequently take a decisions at each stage of the development of the project.

About the authors

E S Sirik

Saint Petersburg State University of Economics and Finance

References

Statistics

Views

Abstract - 230

PDF (Russian) - 1220

Cited-By



Copyright (c) 2016 Economics



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies